Investorideas.com newswire, breaking biotechnology and pharma news

Tuesday, November 28, 2017

Investorideas.com - (CSE: $VRT.C) (OTC: $VRTHF) News: US Patent Office Acknowledges Provisional Patent Application for Use of Specific #Cannabis Strain to Enhance Opioid Analgesia

Investorideas.com - (CSE: $VRT.C) (OTC: $VRTHF) News: US Patent Office Acknowledges Provisional Patent Application for Use of Specific #Cannabis Strain to Enhance Opioid Analgesia



Veritas Pharma Inc. (CSE: VRT; OTC:
VRTHF
;
and Frankfurt: 2VP), (“Veritas” or the “Company”) announces its research arm,
Cannevert Therapeutics Ltd. (“CTL”) filed a provisional patent application to
US Patent and Trademark Office (the “USPTO”) on September 13, 2017 for use of a
specific cannabis strain to enhance the actions of opioid analgesics.  An acknowledgement letter from the USPTO was
received recently which provided a filing number of US 62/558,021 for this
application.

No comments:

Post a Comment